Abstract Background: This study evaluated the timing of dog owner ectoparasiticide purchases to estimate administration compliance and assess the consequent impact of dose purchase gaps on the proportion of time that dogs were protected over a 12-month period. Methods: Ectoparasiticide purchase transactions over a 12-month period were evaluated for 626 US veterinary hospitals to determine […]
Abstract Background: The parthenogenic reproductive ability of Haemaphysalis longicornis, facilitating quick life cycle completion and rapid geographic spread and its pathogen vector potential make infestations a risk to human and canine health. Two 90-day studies were initiated to evaluate the efficacy of a single fluralaner administration for the treatment and prevention of H. longicornis infestations […]
Abstract Background: Adult, nymph, and larval Rhipicephalus sanguineus sensu lato infest dogs and thrive in premises including homes and kennels. Ticks emerge from hiding to seek and attach to dogs, engorge, then leave their hosts to hide then molt or oviposit. This study evaluated the effect of either external or systemic canine treatment on R. […]
Abstract Background: Compliant ectoparasiticide product use is a comprehensive way to control ticks and reduce the risk of tick-borne pathogen transmission to dogs. Because the systemically acting isoxazoline ectoparasiticides require tick attachment for drug delivery, fast speed of kill is essential to minimize tick-borne pathogen transmission risk. Methods: Dogs of satisfactory tick-carrying capacity were randomly […]
A rundown of the features, benefits, and advantages of our canine otitis externa treatments in an easy-to-read, tabular format. Also includes a handy side-by-side ingredient comparison with other products.
The American College of Veterinary Internal Medicine (ACVIM) has published its most recent consensus statement on leptospirosis in dogs. In this session, you will discover what conclusions the 12-member panel was able to reach and how to apply these conclusions in your everyday practice. Perhaps most importantly, learn what the panel concluded with regards to […]
Join Dr. Laura Greene, DVM, DACVIM (SAIM) as she takes us through the NXT generation of vaccines-RNA particle vaccine technology. Come learn not only how Nobivac® NXT Canine Flu H3N2 provides NXT level antibody-mediated and cell-mediated protection, but also to update what we know about canine influenza and why it is vital for pet owners […]
Don’t miss our program “Canine Lyme Disease: The Power of Prevention” where you will gain comprehensive knowledge about this endemic and emerging vector-borne infection that poses a threat to dogs in many regions of the United States. This program will cover Lyme Disease transmission, prevalence and the most up to date information on preventative strategies, […]
In this presentation, we will look at the latest information on parvovirus, including etiology and epidemiology, clinical signs and differential diagnoses, current treatment recommendations, and the effect of maternal antibodies on vaccination success and protocols. We will also discuss parvovirus diagnostics, including their reliability and how to interpret positive and negative test results given the […]
This session will review the many causes of canine cough, or Canine Infectious Respiratory Disease Complex (CIRDC), and a new vaccine to fight against the disease. You’ll learn how to develop vaccine protocols based on the 2022 AAHA vaccine guidelines, the best way to explain the risks of CIRDC to dog owners, how the immune […]